Ahmed Hassan AbdelKhalek (Ahmed AbdelKhalek)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

Microorganisms

The Journal of antibiotics

Scientific reports

Journal of medicinal chemistry

Purdue University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Purdue University Jul 29 2015

United States

PhD student :: Comparative Pathobiology

Publications

Ahmed Hassan AbdelKhalek, Sanjeev K Narayanan
Comparison between Symptomatic and Asymptomatic Mice after Clostridioides difficile Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota. Microorganisms 10 (12) (2022)
Ahmed Hassan AbdelKhalek, Sanjeev K Narayanan
Comparison between Symptomatic and Asymptomatic Mice after Clostridioides difficile Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota. Microorganisms 10 (12) (2022)
Ahmed Hassan AbdelKhalek, Sanjeev K Narayanan
Comparison between Symptomatic and Asymptomatic Mice after Clostridioides difficile Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota. Microorganisms 10 (12) (2022)
Ahmed Hassan AbdelKhalek, Sanjeev K Narayanan
Comparison between Symptomatic and Asymptomatic Mice after Clostridioides difficile Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota. Microorganisms 10 (12) (2022)
Chandradhish Ghosh, Ahmed Hassan AbdelKhalek, Haroon Mohammad, Mohamed N Seleem, Jayanta Haldar
Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection. Scientific reports 10 (1) (2020)
Jatinder Kaur, Xufeng Cao, Nader S Abutaleb, Ahmed Elkashif, Amanda L Graboski, Aaron D Krabill, Ahmed Hassan AbdelKhalek, Weiwei An, Atul Bhardwaj, Mohamed N Seleem, Daniel P Flaherty
Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. Journal of medicinal chemistry 63 (17) (2020)
Ahmed Hassan AbdelKhalek, Haroon Mohammad, Abdelrahman S Mayhoub, Mohamed N Seleem
Screening for potent and selective anticlostridial leads among FDA-approved drugs. The Journal of antibiotics 73 (6) (2020)

Ahmed Hassan AbdelKhalek.css-eqlu8i{font-size:small;padding-left:4px;} (Ahmed AbdelKhalek)

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmed Hassan AbdelKhalek (Ahmed AbdelKhalek)